Biology-oriented drug synthesis (BIODS): In vitro β-glucuronidase inhibitory and in silico studies on 2-(2-methyl-5-nitro-1H-imidazol-1-yl)ethyl aryl carboxylate derivatives.Current study is based on the biology-oriented drug synthesis (BIODS) of 2-(2-methyl-5-nitro-1H-imidazol-1-yl)ethyl aryl carboxylate derivatives 1-26, by treating metronidazole with different aryl and hetero-aryl carboxylic acids in the presence of 1,1'-carbonyl diimidazole (CDI) as a coupling agent. 
BIODS
Biology-oriented drug synthesis (BIODS): In vitro β-glucuronidase inhibitory and in silico studies on 2-(2-methyl-5-nitro-1H-imidazol-1-yl)ethyl aryl carboxylate derivatives.Current study is based on the biology-oriented drug synthesis (BIODS) of 2-(2-methyl-5-nitro-1H-imidazol-1-yl)ethyl aryl carboxylate derivatives 1-26, by treating metronidazole with different aryl and hetero-aryl carboxylic acids in the presence of 1,1'-carbonyl diimidazole (CDI) as a coupling agent. 
BIODS
Structures of all synthetic derivatives were confirmed with the help of various spectroscopic techniques such as EI-MS, 1H -NMR and 13C NMR. 
EI-MS
Structures of all synthetic derivatives were confirmed with the help of various spectroscopic techniques such as EI-MS, 1H -NMR and 13C NMR. 
1H -NMR
Structures of all synthetic derivatives were confirmed with the help of various spectroscopic techniques such as EI-MS, 1H -NMR and 13C NMR. 
13C NMR
CHN elemental analyses were also found in agreement with the calculated values. 
CHN elemental analyses